Track the BioGaia AB share price and the full management transaction log of the company, a listed issuer based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, BioGaia AB has published 10 public disclosures. Market capitalisation: €12.4bn. The latest transaction was filed on 13 February 2026 (Purchase). Among the most active insiders: Anthon Jahreskog. The full history is accessible without an account.
10
Insider Decl.
0
Thresholds
€100,356
9 ops.
Buy Volume
€199
1 ops.
Sell Volume
29Σ signal
Buys €100,356€199 Sells
Fundamental score
Ranked 6,595 of 25,899 companies
63.9
score / 100
Value
38
Quality
90
FCF yld2.4%
Earn yld2.6%
EV/EBITDA28.0x
ROE21%
Gross mgn73%
Net mgn22%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.